IDEX Corporation (NYSE:IEX) reported better-than-expected results for the first quarter of 2019. It pulled off a positive earnings surprise of 5.11%.
The company’s adjusted earnings per share were $1.44, surpassing the Zacks Consensus Estimate of $1.37.
Further, the bottom line increased 12% from the year-ago quarter figure of $1.29. The improvement was driven by healthy organic growth and diligent execution of productivity initiatives.
IDEX generated revenues of $622.2 million in the quarter under review, reflecting year-over-year growth of 2%. The top-line improvement came on the back of 4% growth in organic sales, partially offset by 2% adverse impact of forex woes.
However, the top line lagged the consensus estimate of $635 million by 2%.
In the first quarter, orders increased 4% year over year to $655.5 million. As noted, organically orders improved 6%, acquisitions had positive impact of 1% and foreign currency movements had an adverse 3% impact.
IDEX reports revenues under the segments discussed below:
Net sales of Fluid & Metering Technologies (“FMT”) were $242.5 million, up 4% year over year. Organic net sales grew 6% while forex headwinds had 2% impact.
Revenues from Health & Science Technologies (“HST”) totaled $225.3 million, reflecting year-over-year growth of 2%. Results were driven by 3% organic sales growth and 1% gain from acquisitions, partially offset by forex woes of 2%.
Fire & Safety/Diversified Products (“FSDP”) revenues were $156.2 million, down 2% from the year-ago quarter. Organic sales improved 1% while currency translation had adverse 3% impact.
Margin Details
In the reported quarter, IDEX’s cost of sales increased 0.8% year over year to $338.4 million. It represented 55.4% of the quarter’s revenues compared with 54.8% in the year-ago quarter. Gross margin improved 40 basis points (bps) to 45.6% on the back of benefits from higher volumes, pricing and productivity actions. However, rise in engineering costs played spoilsport. Selling, general and administrative expenses decreased marginally to $136.5 million. It represented 21.9% of revenues compared with 22.5% a year ago.
Adjusted operating income increased 8.1% to $147.8 million, and margin improved 120 bps to 23.8%. On a segmental basis, adjusted operating income for the FMT segment increased 8.4% to $71.9 million and that for HST expanded 2.5% to $54.2 million while for FSDP it increased 1.5% to $40.3 million. Adjusted effective tax rate in the reported quarter was 19.5%.
Balance Sheet and Cash Flow
Exiting the first quarter, IDEX had cash and cash equivalents of $456.1 million, down 2.3% from $466.4 million recorded at the end of the last reported quarter. Long-term borrowings were flat sequentially at $848.4 million.
In the first quarter, the company generated net cash of $88.7 million from operating activities, reflecting growth of 23.7% from the year-ago quarter. Free cash flow was $75.8 million, up 23%.
Outlook
For 2019, adjusted earnings are anticipated to be $5.70-$5.85, higher than $5.60-$5.80 per share guided earlier. Organic revenue growth is estimated to be roughly 4-5%.
For the second quarter, earnings per share are expected to be $1.47-$1.50.
Zacks Rank & Key Picks
IDEX currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the same space are DXP Enterprises, Inc. (NASDAQ:DXPE) , Actuant Corporation (NYSE:ATU) and Cintas Corporation (NASDAQ:CTAS) . While DXP Enterprises sports a Zacks Rank #1 (Strong Buy), Actuant and Cintas carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
DXP Enterprises delivered average earnings surprise of 46.55% in the trailing four quarters.
Actuant pulled off average positive earnings surprise of 11.01% in the trailing four quarters.
Cintas outpaced estimates in the last reported quarter by 6.09%.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
See their latest picks free >>
Cintas Corporation (CTAS): Free Stock Analysis Report
Actuant Corporation (ATU): Free Stock Analysis Report
DXP Enterprises, Inc. (DXPE): Free Stock Analysis Report
IDEX Corporation (IEX): Free Stock Analysis Report
Original post
Zacks Investment Research